Donanemab, CAS 1931944-80-7

Product Description: Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research[1][2].

Applications: Neuroscience-Neurodegeneration

Formula: N/A

References: [1]Stephen Loucian Lowe, et al. Donanemab (LY3002813) dose-escalation study in Alzheimer's disease. Alzheimers Dement (N Y). 2021 Feb 14;7(1):e12112./[2]Mark A Mintun, et al. Donanemab in Early Alzheimer's Disease. N Engl J Med. 2021 May 6;384(18):1691-1704.

CAS Number: 1931944-80-7

Molecular Weight: N/A

Compound Purity: 96.69

Research Area: Neurological Disease

Solubility: 10 mM in DMSO

Target: Amyloid-β

• Artikelnummer: MEXHY-P99859-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99859-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated